These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 32505000)

  • 1. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.
    Hu X; Zhu H; Shen Y; Zhang X; He X; Xu X
    Front Oncol; 2021; 11():696705. PubMed ID: 34367979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
    Xia M; Zu X; Chen Z; Wen G; Zhong J
    Cancer Lett; 2021 Dec; 523():100-110. PubMed ID: 34601022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.
    Lai Y; Huang H; Abudoureyimu M; Lin X; Tian C; Wang T; Chu X; Wang R
    Am J Cancer Res; 2020; 10(12):4066-4084. PubMed ID: 33414986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities.
    Subaiea GM; Syed RU; Afsar S; Alhaidan TMS; Alzammay SA; Alrashidi AA; Alrowaili SF; Alshelaly DA; Alenezi AMSRA
    Pathol Res Pract; 2024 Jan; 253():155022. PubMed ID: 38086292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
    Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
    Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
    Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
    Front Oncol; 2019; 9():1156. PubMed ID: 31750247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
    Fang Y; Zhang X; Huang H; Zeng Z
    J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
    Front Immunol; 2022; 13():847728. PubMed ID: 35281015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate.
    Arefnezhad R; Ashna S; Rezaei-Tazangi F; Arfazadeh SM; Seyedsalehie SS; Yeganeafrouz S; Aghaei M; Sanandaji M; Davoodi R; Abadi SRK; Vosough M
    Cell Biol Int; 2024 May; 48(5):556-576. PubMed ID: 38411312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma.
    Ghionescu AV; Sorop A; Dima SO
    Front Pharmacol; 2023; 14():1270425. PubMed ID: 37767397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome sequencing of hepatocellular carcinoma uncovers multiple types of dysregulated ncRNAs.
    Zhang L; Wang C; Lu X; Xu X; Shi T; Chen J
    Front Oncol; 2022; 12():927524. PubMed ID: 36132143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma.
    Han TS; Hur K; Cho HS; Ban HS
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer.
    Yang S; Sun Z; Zhou Q; Wang W; Wang G; Song J; Li Z; Zhang Z; Chang Y; Xia K; Liu J; Yuan W
    Cancer Manag Res; 2018; 10():2249-2257. PubMed ID: 30100756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Crosstalk Between Regulatory Non-Coding RNAs and Nuclear Factor Kappa B in Hepatocellular Carcinoma.
    Zhang Y; Shao J; Li S; Liu Y; Zheng M
    Front Oncol; 2021; 11():775250. PubMed ID: 34804980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.
    Zhou Z; Wang Z; Gao J; Lin Z; Wang Y; Shan P; Li M; Zhou T; Li P
    Mol Ther Oncolytics; 2022 Jun; 25():98-120. PubMed ID: 35506150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.